Dynavax Technologies | Capitale Di Prestito



Loan Capital Cambiamento Data
AbbVie USD 64.53B 4.19B 2025-03
Adma Biologics USD 72.34M 28.99M 2024-12
Amgen USD 53.76B 253M 2025-06
AstraZeneca USD 25.99B 1.9B 2025-06
Biogen USD 6.28B 1.74B 2025-06
BioMarin Pharmaceutical USD 596.16M 512K 2025-06
Bristol-Myers Squibb USD 44.47B 1.69B 2025-06
Dynavax Technologies USD 220.75M 39.75M 2025-06
Gilead Sciences USD 22.14B 6M 2025-06
Glaxosmithkline GBP 14.64B 1.39B 2024-12
Merck USD 33.97B 484M 2025-06
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 24.06B 2.4B 2025-06
Pfizer USD 57.5B 137M 2025-06
Regeneron Pharmaceuticals USD 1.99B 719.7M 2025-06
Roche Holding CHF 32.1B 1.94B 2024-12
Sarepta Therapeutics USD 1.14B 1.17M 2025-06
TG Therapeutics USD 245.04M 608K 2025-06
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12


Dynavax Technologies Capitale Di Prestito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.